EFFECT OF ANTICOAGULANT, FIBRINOLYTIC, AND ANTIFIBRINOLYTIC AGENTS ON EXPERIMENTAL HYALINE MEMBRANES.
D000614:Aminocaproates; D015119:Aminocaproic Acid; D000818:Animals; D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D003850:Deoxyribonuclease I; D006168:Guinea Pigs; D006493:Heparin; D006801:Humans; D006818:Hyalin; D006819:Hyaline Membrane Disease; D007231:Infant, Newborn; D010100:Oxygen; D010600:Pharmacology; D012106:Research; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D014116:Toxicology
D000614:Aminocaproates; D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D006493:Heparin; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase; D010100:Oxygen; D015119:Aminocaproic Acid
AMINOCAPROIC ACID; EXPERIMENTAL LAB STUDY; GUINEA PIGS; HEPARIN; HYALINE MEMBRANE DISEASE; OXYGEN; PHARMACOLOGY; STREPTODORNASE AND STREPTOKINASE; TOXICOLOGIC REPORT